347 related articles for article (PubMed ID: 28515072)
1. ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.
Gong Y; Fu Z; Liegl R; Chen J; Hellström A; Smith LE
Am J Clin Nutr; 2017 Jul; 106(1):16-26. PubMed ID: 28515072
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.
Gong Y; Fu Z; Edin ML; Liu CH; Wang Z; Shao Z; Fredrick TW; Saba NJ; Morss PC; Burnim SB; Meng SS; Lih FB; Lee KS; Moran EP; SanGiovanni JP; Hellström A; Hammock BD; Zeldin DC; Smith LE
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1919-27. PubMed ID: 27417579
[TBL] [Abstract][Full Text] [Related]
4. ω-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer.
Wang W; Zhu J; Lyu F; Panigrahy D; Ferrara KW; Hammock B; Zhang G
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():13-20. PubMed ID: 25019221
[TBL] [Abstract][Full Text] [Related]
5. 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids.
Sapieha P; Stahl A; Chen J; Seaward MR; Willett KL; Krah NM; Dennison RJ; Connor KM; Aderman CM; Liclican E; Carughi A; Perelman D; Kanaoka Y; Sangiovanni JP; Gronert K; Smith LE
Sci Transl Med; 2011 Feb; 3(69):69ra12. PubMed ID: 21307302
[TBL] [Abstract][Full Text] [Related]
6. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina.
SanGiovanni JP; Chew EY
Prog Retin Eye Res; 2005 Jan; 24(1):87-138. PubMed ID: 15555528
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.
Hartman GD; Lambert-Cheatham NA; Kelley MR; Corson TW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638620
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 oxidase 2J inhibition suppresses choroidal neovascularization in mice.
Gong Y; Tomita Y; Edin ML; Ren A; Ko M; Yang J; Bull E; Zeldin DC; Hellström A; Fu Z; Smith LEH
Metabolism; 2022 Sep; 134():155266. PubMed ID: 35868524
[TBL] [Abstract][Full Text] [Related]
9. The role of the retinal pigment epithelium and Müller cells secretome in neovascular retinal pathologies.
Araújo RS; Santos DF; Silva GA
Biochimie; 2018 Dec; 155():104-108. PubMed ID: 29960032
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization.
Yanai R; Mulki L; Hasegawa E; Takeuchi K; Sweigard H; Suzuki J; Gaissert P; Vavvas DG; Sonoda KH; Rothe M; Schunck WH; Miller JW; Connor KM
Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9603-8. PubMed ID: 24979774
[TBL] [Abstract][Full Text] [Related]
11. Current perspectives on established and novel therapies for pathological neovascularization in retinal disease.
Campbell M; Doyle SL
Biochem Pharmacol; 2019 Jun; 164():321-325. PubMed ID: 31039332
[TBL] [Abstract][Full Text] [Related]
12. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.
Nguyen QD; De Falco S; Behar-Cohen F; Lam WC; Li X; Reichhart N; Ricci F; Pluim J; Li WW
Acta Ophthalmol; 2018 Feb; 96(1):e1-e9. PubMed ID: 27874278
[TBL] [Abstract][Full Text] [Related]
13. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
[TBL] [Abstract][Full Text] [Related]
14. Mfsd2a overexpression alleviates vascular dysfunction in diabetic retinopathy.
Zhang CL; Wang HL; Li PC; Hong CD; Chen AQ; Qiu YM; Zeng AP; Zhou YF; Hu B; Li YN
Pharmacol Res; 2021 Sep; 171():105755. PubMed ID: 34229049
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration.
Sarparast M; Dattmore D; Alan J; Lee KSS
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33207662
[TBL] [Abstract][Full Text] [Related]
16. n-3 PUFA Supplementation Alters Retinal Very-Long-Chain-PUFA Levels and Ratios in Diabetic Animal Models.
Gorusupudi A; Chang FY; Nelson K; Hageman GS; Bernstein PS
Mol Nutr Food Res; 2019 Aug; 63(15):e1801058. PubMed ID: 31106474
[TBL] [Abstract][Full Text] [Related]
17. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.
Connor KM; SanGiovanni JP; Lofqvist C; Aderman CM; Chen J; Higuchi A; Hong S; Pravda EA; Majchrzak S; Carper D; Hellstrom A; Kang JX; Chew EY; Salem N; Serhan CN; Smith LEH
Nat Med; 2007 Jul; 13(7):868-873. PubMed ID: 17589522
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief report.
Shao Z; Fu Z; Stahl A; Joyal JS; Hatton C; Juan A; Hurst C; Evans L; Cui Z; Pei D; Gong Y; Xu D; Tian K; Bogardus H; Edin ML; Lih F; Sapieha P; Chen J; Panigrahy D; Hellstrom A; Zeldin DC; Smith LE
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):581-6. PubMed ID: 24458713
[TBL] [Abstract][Full Text] [Related]
19. Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.
Stahl A; Krohne TU; Sapieha P; Chen J; Hellstrom A; Chew E; Holz FG; Smith LE
Br J Ophthalmol; 2011 Nov; 95(11):1496-501. PubMed ID: 21421650
[TBL] [Abstract][Full Text] [Related]
20. Omega-3/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity.
Fu Z; Yan W; Chen CT; Nilsson AK; Bull E; Allen W; Yang J; Ko M; SanGiovanni JP; Akula JD; Talukdar S; Hellström A; Smith LEH
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
